These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11011247)
1. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease]. Dubuquoy L; Bourdon C; Peuchmaur M; Leibowitz MD; Nutten S; Colombel JF; Auwerx J; Desreumaux P Gastroenterol Clin Biol; 2000; 24(8-9):719-24. PubMed ID: 11011247 [TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846 [TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. Zhang M; Deng C; Zheng J; Xia J; Sheng D Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535 [TBL] [Abstract][Full Text] [Related]
4. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice. Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408 [TBL] [Abstract][Full Text] [Related]
5. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice. Zhao Y; Zhang S; Jiang L; Jiang J; Liu H J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961 [TBL] [Abstract][Full Text] [Related]
6. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649 [TBL] [Abstract][Full Text] [Related]
7. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions. Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746 [TBL] [Abstract][Full Text] [Related]
8. The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Bai A; Guo Y; Lu N Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic changes in TNBS-induced colitis in mice. Barthet M; Dubucquoy L; Garcia S; Gasmi M; Desreumaux P; Colombel JF; Grimaud JC; Iovanna J; Dagorn JC Gastroenterol Clin Biol; 2003 Oct; 27(10):895-900. PubMed ID: 14631304 [TBL] [Abstract][Full Text] [Related]
10. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis. Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968 [TBL] [Abstract][Full Text] [Related]
11. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893 [TBL] [Abstract][Full Text] [Related]
14. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect. Trifilieff A; Bench A; Hanley M; Bayley D; Campbell E; Whittaker P Br J Pharmacol; 2003 May; 139(1):163-71. PubMed ID: 12746235 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. Desreumaux P; Dubuquoy L; Nutten S; Peuchmaur M; Englaro W; Schoonjans K; Derijard B; Desvergne B; Wahli W; Chambon P; Leibowitz MD; Colombel JF; Auwerx J J Exp Med; 2001 Apr; 193(7):827-38. PubMed ID: 11283155 [TBL] [Abstract][Full Text] [Related]
16. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806 [TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425 [TBL] [Abstract][Full Text] [Related]
18. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375 [TBL] [Abstract][Full Text] [Related]